When prostate cancer cells were either pretreated with MSA followed by CoCl 2 or co-treated with MSA and CoCl 2, there was a marked decrease in HIF-1α binding or protein expression, respectively. The gene discussed is HIF1A; the disease is prostate carcinoma.